Back
Trinity Biotech PLC Vs. Adaptimmune Therapeutics PLC Industry Stock Comparison
Sell
5
TRIB
Trinity Biotech PLC
Last Price:
1.21
Seasonality Move:
6.79%
Sell
20
ADAP
Adaptimmune Therapeutics PLC
Last Price:
0.66
Seasonality Move:
50.57%
Sell
5
Trinity Biotech PLC (TRIB)
is a Sell
Is Trinity Biotech PLC a Buy, Sell or Hold?
- The current Trinity Biotech PLC [TRIB] share price is $1.30. The Score for TRIB is 5, which is 90% below its historic median score of 50, and infers higher risk than normal.
- TRIB is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
20
Adaptimmune Therapeutics PLC (ADAP)
is a Sell
Is Adaptimmune Therapeutics PLC a Buy, Sell or Hold?
- The current Adaptimmune Therapeutics PLC [ADAP] share price is $0.64. The Score for ADAP is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
- ADAP is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
TRIB Stock Price Chart
What is Trinity Biotech PLC's stock price today?
-
The Trinity Biotech PLC share price today is $1.30
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TRIB is experiencing slight buying pressure.
ADAP Stock Price Chart
What is Adaptimmune Therapeutics PLC's stock price today?
-
The Adaptimmune Therapeutics PLC share price today is $0.64
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ADAP is experiencing selling pressure, which indicates risk of future bearish movement.
TRIB Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.1 | Sell |
| Relative Strength Index (14 RSI): | 34.97 | Sell |
| Chaikin Money Flow: | 4098 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.42 - 1.86) | Sell |
| Bollinger Bands (100): | (1.4 - 2.62) | Sell |
ADAP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.06 | Sell |
| Relative Strength Index (14 RSI): | 36.24 | Sell |
| Chaikin Money Flow: | -608296 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.66 - 0.82) | Sell |
| Bollinger Bands (100): | (0.81 - 1.21) | Sell |
TRIB Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.4 | Sell |
| 20-day SMA: | 1.64 | Sell |
| 50-day SMA: | 1.54 | Sell |
| 200-day SMA: | 2.04 | Sell |
| 8-day EMA: | 1.4 | Sell |
| 20-day EMA: | 1.53 | Sell |
| 50-day EMA: | 1.65 | Sell |
| 200-day EMA: | 2.12 | Sell |
ADAP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.66 | Sell |
| 20-day SMA: | 0.73 | Sell |
| 50-day SMA: | 0.85 | Sell |
| 200-day SMA: | 1.12 | Sell |
| 8-day EMA: | 0.67 | Sell |
| 20-day EMA: | 0.73 | Sell |
| 50-day EMA: | 0.83 | Sell |
| 200-day EMA: | 1 | Sell |
Trinity Biotech PLC Earnings Growth & TRIB Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.33 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.34 per share, and an increase next year of $0.84 per share.
Adaptimmune Therapeutics PLC Earnings Growth & ADAP Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.36 per share, and a decrease next year of $0.33 per share.
Trinity Biotech PLC Technical Analysis
| Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Adaptimmune Therapeutics PLC Technical Analysis
| Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||